Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02094638
Other study ID # PekingUTH-Pharmacy-003
Secondary ID
Status Completed
Phase N/A
First received March 20, 2014
Last updated February 18, 2016
Start date January 2014

Study information

Verified date February 2016
Source Peking University Third Hospital
Contact n/a
Is FDA regulated No
Health authority China: State Administration of Traditional Chinese Medicine of the People's Republic of China
Study type Observational [Patient Registry]

Clinical Trial Summary

Tanreqing Injection is widely used in respiratory disease with Chinese medicine syndrome of retention of phlegm and heat in Fei. This study record clinical use of Tanreqing Injection in the real world, observe the adverse drug reactions/ adverse drug events during treatment, and figure out why Tanreqing induced severe allergic reaction happens.


Description:

As a compound traditional Chinese medicine, Tanreqing Injection was approved by China Food and Drug Administration(CFDA) in 2003, and widely used respiratory disease, such as biofilm related upper respiratory infections, pneumonia and bronchitis. During its 11 years marketing in China, there was hardly any serious adverse drug reactions except for a few cases reported as severe allergic reaction. In this study, clinical pharmacists in selected hospitals will not only record the clinical use and the adverse drug reactions/ adverse drug events of this injection, but also try to figure out why drug-induced severe allergic reaction happens through a nested case-control study. This real world study for Tanreqing Injection with 30400 patients will be conducted from January.2014 to June.2016.


Recruitment information / eligibility

Status Completed
Enrollment 30400
Est. completion date
Est. primary completion date August 2015
Accepts healthy volunteers No
Gender Both
Age group 24 Months and older
Eligibility Inclusion Criteria:

- Patients who use the Tanreqing Injection in selected hospitals in China, including inpatient and outpatient.

- Outpatients will be only in some hospitals which can get the patients' complete information.

Exclusion Criteria:

- Patients who are less than 24 months.

Study Design

Observational Model: Cohort


Related Conditions & MeSH terms


Locations

Country Name City State
China People's Hospital of Rongcheng Baoding Hebei
China The Third Affiliated Hospital of Inner Mongolia Medical College Baotou Inner Mongolia
China Beijing Geriatric Hospital Beijing Beijing
China Beijing Luhe Hospital, Capital Medical University Beijing Beijing
China Peking university third hospital Beijing
China The 263rd Hospital of Chinese People's Liberation Army Beijing Beijing
China The Fengtai district Hospital of Integrated TCM & WM Beijing Beijing
China Bijie First Municipal People's Hospital Bijie Guizhou
China People's Hospital of Cangzhou Cangzhou Hebei
China The First Hospital of Jilin University Changchun Jilin
China The Second Hospital of Jilin University Changchun Jilin
China The Fourth Hospital of Changsha Changsha Hunan
China the Second Xiangya Hospital of Central South University Changsha Hunan
China ShuangLiu Hospital of Traditional Chinese Medical Chengdu Sichuan
China Sichuan Provincial People's Hospital Chengdu Sichuan
China The Third People's Hospital of Chengdu Chengdu Sichuan
China West China Hospital, Sichuan University Chengdu Sichuan
China Chongqing Jiulongpo First People's Hospital Chongqing Chongqing
China Chongqing Kaixian County People's Hospital Chongqing Chongqing
China Chongqing Three Gorges Central Hospital Chongqing Chongqing
China Chongqing Traditional Chinese Medicine Hospital Chongqing Chongqing
China The Second Affiliated Hospital of Chongqing Medical University Chongqing Chongqing
China The Third People's Hospital of Chongqing Chongqing Chongqing
China Traditional Chinese Medical Hospital of Bai Autonomous Prefecture of Dali Dali Yunnan
China Fifth Hospital of Datong Datong Shanxi
China DuJiangyan Traditional Chinese Medicine Hospital Dujiangyan Sichuan
China Fenyang Hospital of Shanxi Province Fenyang Shanxi
China Guiyang Children's Hospital Guiyang Guizhou
China Guiyang Pulmonary Hospital Guiyang Guizhou
China Guizhou Cancer Hospital Guiyang Guizhou
China The 44th Hospital of chinese People's Liberation Army Guiyang Guizhou
China The Affiliated Hospital of Hainan medical College Haikou Hainan
China First Hospital of Handan City Handan Hebei
China Zhejiang Provincial Hospital of TCM Hangzhou Zhejiang
China Anhui Provincial Children's Hospital Hefei Anhui
China Hejian Municipal People's Hospital Hejian Hebei
China The First Hospital Of Huhhot Huhehaote Inner Mongolia
China The fourth Hospital of Inner Mongolia Huhehaote Inner Mongolia
China The Third People's Hospital of Huizhou Huizhou Guangdong
China Affiliated Hospital of Shandong University of Traditional Chinese Medicine Jinan Shandong
China Shandong Cancer Hospital Jinan Shandong
China The Second People's Hospital of Jinzhong Jinzhong Shanxi
China First Affiliated Hospital of Kunming Medical University Kunming Yunnan
China Second Affiliated Hospital of Kunming Medical University Kunming Yunnan
China Gansu Provincial Hospital of Traditional Chinese Medicine Lanzhou Gansu
China Lanzhou Petrochemical General Hospital Lanzhou Gansu
China Jiangxi Provincial People's Hospital Nanchang Jiangxi
China The First Hospital of Nanchang Nanchang Jiangxi
China The Second Hospital of Nanchang Nanchang Jiangxi
China Traditional Chinese Medical Hospital of Jiangxi Province Nanchang Jiangxi
China People's Hospital of Nanbu County Nanchong Sichuan
China Jiangning District Hospital of Traditional Chinese Medicine Nanjing Jiangsu
China Ningbo First Hospital Ningbo Zhejiang
China The 152nd Hospital of chinese People's Liberation Army Pingdingshan Henan
China The First Hospital of Qinhuangdao Qinhuangdao Hebei
China Shanghai Changzheng Hospital Shanghai Shanghai
China Shanghai First People's Hospital Branch Shanghai Shanghai
China Shanghai Minhang District Central Hospital Shanghai Shanghai
China Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine Shanghai Shanghai
China Wu Song Central Hospital of Shanghai Shanghai Shanghai
China Shenyang 242 Hospital Shenyang Liaoning
China The Third People's Hospital of Shenzhen Shenzhen Guangdong
China Bethune International Peace Hospital of the Chinese PLA Shijiazhuang Hebei
China Hebei Zhaoxian People's Hospital Shijiazhuang Hebei
China the Second Hospital of Hebei Medical University Shijiazhuang Hebei
China The Center Hospital of Shuozhou Shuozhou Shanxi
China Maternal and Child Health Care Hospital of Taiyuan Taiyuan Shanxi
China Shanxi Maternity and Children Health Hospital Taiyuan Shanxi
China The 254th Hospital of chinese People's Liberation Army Tianjin Tianjin
China The 464th Hospital of chinese People's Liberation Army Tianjin Tianjin
China The Second Affiliated Hospital of Wenzhou Medical College Wenzhou Zhejiang
China Wenzhou Central Hospital Wenzhou Zhejiang
China Wenzhou Yueqing People's Hospital Wenzhou Zhejiang
China Hubei Cancer Hospital Wuhan Hubei
China Hubei Xinhua Hospital Wuhan Hubei
China Hubei Zhongshan Hospital Affiliated to Wuhan University Wuhan Hubei
China The Second Hospital of Wulanchabu City Wulanchabu Inner Mongolia
China People's Hospital of Xinjiang Uigur Autonomous Region Wulumuqi Xinjiang
China Qinghai Women and Childhood Hospital Xining Qinghai
China Xinle Municipal Hospital of Hebei Xinle Hebei
China Xintai People's Hospital Xintai Shandong
China The First People's Hospital of Yangzhou City Yangzhou Jiangsu
China Yantai Municipal Laiyang Central Hospital Yantai Shandong
China Chinese Traditional Medicine Hospital of Ningxia Autonomous Region Yinchuan Ningxia
China General Hospital of Ningxia Medical University Yinchuan Ningxia
China The First People's Hospital of Yinchuan Yinchuan Ningxia
China Henan Province Hospital of TCM Zhengzhou Henan
China The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan
China Zhongshan Municipal People's Hospital Zhongshan Guangdong
China Affiliated Hospital of Zunyi Medical College Zunyi Guizhou

Sponsors (92)

Lead Sponsor Collaborator
Suodi ZHAI Anhui Provincial Children's Hospital, Beijing Geriatric Hospital, Beijing Luhe Hospital, Capital Medical University, Bethune International Peace Hospital of the Chinese PLA, Bijie First Municipal People's Hospital, Cancer Hospital of Guizhou Province, Central South University, Chongqing Jiulongpo First People's Hospital, Chongqing Kaixian County People's Hospital, Chongqing Three Gorges Central Hospital, Chongqing Traditional Chinese Medicine Hospital, DuJiangyan Traditional Chinese Medicine Hospital, Fengtai district Hospital of Chinese and Western medicine, Beijing, Fenyang Hospital of Shanxi Province, First Hospital of Handan City, First Hospital of Jilin University, Gansu Provincial Hospital, General Hospital of Ningxia Medical University, Guiyang Children's Hospital, Guiyang Pulmonary Hospital, Hebei Zhaoxian People's Hospital, Hejian Municipal People's Hospital, Henan Province Hospital of TCM, Hubei Cancer Hospital, Hubei Xinhua Hospital, Hubei Zhongshan Hospital Affiliated to Wuhan University, Jiangning District Hospital of Traditional Chinese Medicine, Jiangxi Provincial People's Hopital, Lanzhou Petrochemical General Hospital, Maternal and Child Health Care Hospital of Taiyuan, Ningbo First Hospital, Peking University, People's Hospital of Cangzhou, People's Hospital of Nanbu County, People's Hospital of Rongcheng, People's Hospital of Xinjiang Uigur Autonomous Region, Qinghai Women and Childhood Hospital, Second Affiliated Hospital of Guangzhou Medical University, Second Affiliated Hospital of Wenzhou Medical University, Second Hospital of Jilin University, Shandong Cancer Hospital, Shandong University of Traditional Chinese Medicine, Shanghai Changzheng Hospital, Shanghai First People's Hospital Branch, Shanghai Kaibao Pharmaceutical CO.,LTD., Shanghai Minhang District Central Hospital, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanxi Maternity and Children Health Hospital, Shenyang 242 Hospital, Shenzhen Third People's Hospital, ShuangLiu Hospital of Traditional Chinese Medical, Sichuan Provincial People's Hospital, The 152nd Hospital of chinese People's Liberation Army, The 254th Hospital of chinese People's Liberation Army, The 263rd Hospital of Chinese People's Liberation Army, The 44th Hospital of chinese People's Liberation Army, The 464th Hospital of chinese People's Liberation Army, The Affiliated Hospital of Hainan medical College, The Center Hospital of Shuozhou, The Chengdu Third People's Hospital, The Fifth People's Hospital of Datong, The First Affiliated Hospital of Kunming Medical College, The First Affiliated Hospital of Zhengzhou University, The First Hospital Of Huhhot, The First Hospital of Nanchang, The First Hospital of Qinhuangdao, The First People's Hospital of Yangzhou City, The First People's Hospital of Yinchuan, The Fourth Hospital of Changsha, The fourth Hospital of Inner Mongolia, The Second Affiliated Hospital of Chongqing Medical University, The Second Affiliated Hospital of Kunming Medical University, The Second Hospital of Hebei Medical University, The Second Hospital of Nanchang, The Second Hospital of Wulanchabu City, The Second People's Hospital of Jinzhong, The Third Affiliated Hospital of Inner Mongolia Medical College, The Third People's Hospital of Chongqing, Traditional Chinese Medical Hospital of Bai Autonomous Prefecture of Dali, Traditional Chinese Medical Hospital of Jiangxi Province, Traditional Chinese Medicine Hospital of the Ningxia Hui Autonomous Region, Wenzhou Yueqing People's Hospital, West China Hospital, Wu Song Central Hospital of Shanghai, Xinle Municipal Hospital of Hebei, Xintai People's Hospital, Yantai Municipal Laiyang Central Hospital, Yunnan Provinical Hospital of Traditional Chinese Medicine, Zhejiang Provincial Hospital of TCM, Zhongshan People's Hospital, Guangdong, China, Zunyi Medical College

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other Related Risk Factors in severe allergic reaction of Tanreqing Injection 30 months Yes
Primary Incidence of adverse drug reaction of Tanreqing Injection 30 months Yes
Secondary Outcomes of the patients who experienced an adverse drug reaction of Tanreqing Injection Outcomes including cure, improved, null, or death. 30 months Yes
Secondary Administration of Tanreqing Injection in real world 30 months Yes
Secondary Population characteristics of the adverse drug reaction of Tanreqing Injection 30 months Yes
Secondary Off-lable use of Tanreqing Injection 30 months Yes
Secondary Drug combination of Tanreqing Injection in real world 30 months Yes
See also
  Status Clinical Trial Phase
Suspended NCT02559960 - Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study
Completed NCT01946919 - Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
Recruiting NCT04154553 - Pharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy Failure
Completed NCT01732302 - Educational Intervention to Reduce Drug-related Hospitalizations in Elderly Primary Health Care Patients N/A
Completed NCT05224804 - Pharmacists' Knowledge and Attitudes About ADRs Reporting and Pharmacovigilance Practice in Egyptian Hospitals
Completed NCT02297126 - A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program N/A
Completed NCT03093818 - PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions N/A
Not yet recruiting NCT04568668 - Evaluating ActionADE in Reducing Adverse Drug Reactions N/A
Recruiting NCT02012504 - Antidepressant Monotherapy on Depressive and Anxiety Symptom in Chinese Patients Phase 0
Completed NCT01872520 - Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World Study N/A
Completed NCT01467050 - Prevention of Adverse Drug Events (ADEs) in Hospitalised Older Patients Phase 4
Completed NCT01679964 - Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study Phase 4
Recruiting NCT01906710 - the Pharmacy Intervention Team Hospital-based (PITH) for People Study: Effect on Clinical and Economic Outcomes N/A
Completed NCT02888834 - Serious Adverse Drug Reaction and Their Preventability N/A
Completed NCT02838212 - Adverse Drug Reactions With Fatal Outcome N/A
Completed NCT02159209 - The Drug Induced Renal Injury Consortium N/A
Completed NCT02134587 - Educational Intervention in Pharmacovigilance for Hospital Health Professionals N/A
Completed NCT04553107 - Reducing Costs by Deprescribing Medications N/A
Recruiting NCT06219720 - The Texas Interprofessional Pharmacogenomics (IPGx)
Recruiting NCT05508763 - Personalised Therapeutics @LUMC